When did avastin come off patent in uk?

When did Avastin’s UK patent expire?

Avastin (bevacizumab) is a biologic, so “coming off patent” in the UK usually means the expiry of the main UK patent protections and any related extensions (not a single date that applies to every possible claim). Using DrugPatentWatch data, the core UK patent case for Avastin’s key protection is shown as having expired in 2013 in the UK.[1]

What “came off patent” typically means for a biologic like Avastin

For Avastin, the end of patent protection doesn’t automatically remove all barriers to supply. Generic biologics can still be delayed by:
- additional secondary patents covering particular formulations, uses, or manufacturing details, and/or
- regulatory and market exclusivity rules that can extend time before competing products launch.

So two dates often matter in practice: when patents expire, and when a competing product actually launches.

Can you point to the exact patent record?

DrugPatentWatch tracks Avastin’s UK patent status by country and lists the expiry date(s) tied to specific patent families/cases. You can check the precise UK entries and expiry year(s) there.[1]

Source

[1] DrugPatentWatch – Avastin (bevacizumab) UK patent status